Clinical efficacy of intravenous colistin therapy in combination with ceftazidime in severe MDR P. aeruginosa systemic infections in two haematological patients
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
Falagas M.E., Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40, 9, 1333-1341, 2005.
Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections
Tascini C., Gemignani G., Ferranti S., et al. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections. J. Chemother. 16, 3, 282-287, 2004.
Adverse effects of sodium colistimethate: Manifestations and specific reaction rates during 317 courses of therapy
Koch-Weser J., Sidel V.W., Federman E.B. et al. Adverse effects of sodium colistimethate: manifestations and specific reaction rates during 317 courses of therapy. Ann. Intern. Med. 72, 6, 857-868, 1970.
Bronchoconstriction following nebulised colistin in cystic fibrosis
Cunningham S., Prasad A., Collyer L. et al. Bronchoconstriction following nebulised colistin in cystic fibrosis. Arch. Dis. Child. 84, 5, 432-433, 2001.
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis
Kasiakou S.K., Michaloupoulos A.S., Soteriades E.S. et al. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Antimicrob. Agents Chemother. 49, 8, 3136-3146, 2005.
Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: The renaissance of an old antibiotic
Michaloupoulos A.S., Tsiodras S., Rellos K., Mentzelopoulos S., Falagas M.E. Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: the renaissance of an old antibiotic. Clin. Microbiol. Infect. 11, 2, 115-121, 2004.
Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia - Ciprofloxacin versus co-trimoxazole plus colistin
Donnelly J.P., Meschmeyer G., Daenen S. Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia - ciprofloxacin versus co-trimoxazole plus colistin. Eur. J. Cancer 28, 4, 873-878, 1992.